Jonathan W. Haskins

Genotype-selective combination therapies for melanoma identified by high-throughput drug screening.

M. Held, C. G. Langdon, J. Platt, 2013, Cancer discovery.

Seasonal variation and correlation between corticosterone and the antioxidant uric acid during stress in the Northern Cardinal (Cardinalis cardinalis)

Jonathan W. Haskins, B. Walker, Frank A Spizzoucco, 2017, Journal of experimental zoology. Part A, Ecological and integrative physiology.

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.

D. Nguyen, Jonathan W. Haskins, D. Stern, 2013, Cancer research.

non-small cell lung carcinoma invasion and brain metastasis EGF Receptor activates MET through MAP kinases to enhance

Jonathan W. Haskins, D. Stern, Nguyen, 2013 .

Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake

J. Kelleher, R. Means, Y. Suárez, 2015, Science Signaling.

Neuregulin 1–activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration

D. Nguyen, Jonathan W. Haskins, D. Stern, 2014, Science Signaling.

Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis

R. Mamillapalli, Jonathan W. Haskins, D. Stern, 2014, Breast Cancer Research.

Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells

J. Platt, Zongzhi Z. Liu, Jonathan W. Haskins, 2014, Molecular Cancer Research.

Genomics Convergent and Divergent Cellular Responses by ErbB 4 Isoforms in Mammary Epithelial Cells

J. Platt, Zongzhi Z. Liu, Jonathan W. Haskins, 2014 .